The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., lost 7.5 percent in the four days the market was open after President’s Day. The North American Marijuana Index, which also includes Canadian stocks, shed 4 percent of its value.
“This was one of the slowest weeks of the year in terms of substantive news, particularly in Canada. Volumes fell across the board and prices declined,” 420 Investor Alan Brochstein told Benzinga. “Canadian LPs began the year with a surge but are now trading on average only 1 percent higher than where they ended in 2017.
“In the U.S., it is clear that traders have left many of the speculative penny stocks.”
Here are some of the top marijuana stocks in U.S. exchanges and how they performed this week:
22nd Century Group Inc (NYSE: XXII): down 11.9 percent. Aphria Inc (OTC: APHQF): down 1.7 percent. Aurora Cannabis Inc (OTC: ACBFF): up 3.5 percent. Cannabis Sativa Inc (OTC: CBDS): down 3.4 percent. CannTrust Holdings Inc (OTC: CNTTF): down 0.7 percent. Canopy Growth Corp (OTC: TWMJF): up 4.2 percent. Cronos Group Inc (OTC: PRMCF): down 2.9 percent. GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): down 11.8 percent. India Globalization Capital, Inc. (NYSE: IGC): down 11.9 percent. MedReleaf Corp (OTC: MEDFF): down 10.5 percent. Scotts Miracle-Gro Co (NYSE: SMG): down 0.3 percent. THC Biomed Intl Ltd (OTC: THCBF): down 3.5 percent. Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): down 5.9 percent. In The News
GW Pharmaceuticals plummeted after the company reported discouraging results for its Phase 2a study evaluating the efficacy and safety of GWP42006